# Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

> **NCT00716651** · PHASE2 · COMPLETED · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 10 (actual)

## Conditions studied

- Churg Strauss Syndrome

## Interventions

- **DRUG:** mepolizumab

## Key facts

- **NCT ID:** NCT00716651
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716651, "Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00716651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*